Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Anti-CD45RB Antibody Therapy Attenuates Renal Ischemia-Reperfusion Injury by Inducing Regulatory B Cells.

Fang T, Koo TY, Lee JG, Jang JY, Xu Y, Hwang JH, Park S, Yan JJ, Ryu JH, Ryu YM, Kim SY, Suh KS, Yang J.

J Am Soc Nephrol. 2019 Oct;30(10):1870-1885. doi: 10.1681/ASN.2018101067. Epub 2019 Jul 11.

PMID:
31296607
2.

Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury.

Kinsey GR, Sharma R, Huang L, Li L, Vergis AL, Ye H, Ju ST, Okusa MD.

J Am Soc Nephrol. 2009 Aug;20(8):1744-53. doi: 10.1681/ASN.2008111160. Epub 2009 Jun 4.

3.

IL-2/anti-IL-2 complex attenuates renal ischemia-reperfusion injury through expansion of regulatory T cells.

Kim MG, Koo TY, Yan JJ, Lee E, Han KH, Jeong JC, Ro H, Kim BS, Jo SK, Oh KH, Surh CD, Ahn C, Yang J.

J Am Soc Nephrol. 2013 Oct;24(10):1529-36. doi: 10.1681/ASN.2012080784. Epub 2013 Jul 5.

4.

T-cell immunoglobulin mucin-3 determines severity of liver ischemia/reperfusion injury in mice in a TLR4-dependent manner.

Uchida Y, Ke B, Freitas MC, Yagita H, Akiba H, Busuttil RW, Najafian N, Kupiec-Weglinski JW.

Gastroenterology. 2010 Dec;139(6):2195-206. doi: 10.1053/j.gastro.2010.07.003. Epub 2010 Jul 13.

5.

The P2X7 receptor antagonist, oxidized adenosine triphosphate, ameliorates renal ischemia-reperfusion injury by expansion of regulatory T cells.

Koo TY, Lee JG, Yan JJ, Jang JY, Ju KD, Han M, Oh KH, Ahn C, Yang J.

Kidney Int. 2017 Aug;92(2):415-431. doi: 10.1016/j.kint.2017.01.031. Epub 2017 Apr 8.

PMID:
28396117
6.

The pathological role of IL-18Rα in renal ischemia/reperfusion injury.

Yano T, Nozaki Y, Kinoshita K, Hino S, Hirooka Y, Niki K, Shimazu H, Kishimoto K, Funauch M, Matsumura I.

Lab Invest. 2015 Jan;95(1):78-91. doi: 10.1038/labinvest.2014.120. Epub 2014 Oct 20.

7.

Potentiating Tissue-Resident Type 2 Innate Lymphoid Cells by IL-33 to Prevent Renal Ischemia-Reperfusion Injury.

Cao Q, Wang Y, Niu Z, Wang C, Wang R, Zhang Z, Chen T, Wang XM, Li Q, Lee VWS, Huang Q, Tan J, Guo M, Wang YM, Zheng G, Yu D, Alexander SI, Wang H, Harris DCH.

J Am Soc Nephrol. 2018 Mar;29(3):961-976. doi: 10.1681/ASN.2017070774. Epub 2018 Jan 2.

8.

T-cell immunoglobulin and mucin domain 4 (TIM-4) signaling in innate immune-mediated liver ischemia-reperfusion injury.

Ji H, Liu Y, Zhang Y, Shen XD, Gao F, Busuttil RW, Kuchroo VK, Kupiec-Weglinski JW.

Hepatology. 2014 Dec;60(6):2052-2064. doi: 10.1002/hep.27334. Epub 2014 Oct 29.

9.

Effects of combined T- and B-cell deficiency on murine ischemia reperfusion injury.

Burne-Taney MJ, Yokota-Ikeda N, Rabb H.

Am J Transplant. 2005 Jun;5(6):1186-93.

10.

Deletion of regulatory T cells supports the development of intestinal ischemia-reperfusion injuries.

Yang X, Bai H, Wang Y, Li J, Zhou Q, Cai W, Han J, Zhu X, Dong M, Hu D.

J Surg Res. 2013 Oct;184(2):832-7. doi: 10.1016/j.jss.2013.05.014. Epub 2013 May 25.

PMID:
23731680
11.

Enhanced activation of interleukin-10, heme oxygenase-1, and AKT in C5aR2-deficient mice is associated with protection from ischemia reperfusion injury-induced inflammation and fibrosis.

Thorenz A, Derlin K, Schröder C, Dressler L, Vijayan V, Pradhan P, Immenschuh S, Jörns A, Echtermeyer F, Herzog C, Chen R, Rong S, Bräsen JH, van Kooten C, Kirsch T, Klemann C, Meier M, Klos A, Haller H, Hensen B, Gueler F.

Kidney Int. 2018 Oct;94(4):741-755. doi: 10.1016/j.kint.2018.04.005. Epub 2018 Jun 21.

PMID:
29935951
12.

Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.

Liu Y, Ji H, Zhang Y, Shen X, Gao F, He X, Li GA, Busuttil RW, Kuchroo VK, Kupiec-Weglinski JW.

J Hepatol. 2015 Mar;62(3):563-72. doi: 10.1016/j.jhep.2014.10.034. Epub 2014 Oct 31.

13.

Identification of the Subsets of IL-10-Producing Regulatory B Cells in the Course of Tolerance Induction and Maintenance in Islet Allotransplantation.

Li S, Li X, Yang M, Wei L, Wei L, Deng S, Zhao G.

Transplant Proc. 2018 Dec;50(10):3900-3905. doi: 10.1016/j.transproceed.2018.04.065. Epub 2018 May 4.

PMID:
30577284
14.

MicroRNA 26a modulates regulatory T cells expansion and attenuates renal ischemia-reperfusion injury.

Liang S, Wang W, Gou X.

Mol Immunol. 2015 Jun;65(2):321-7. doi: 10.1016/j.molimm.2015.02.003. Epub 2015 Feb 28.

PMID:
25728641
15.

The emerging role of T cell immunoglobulin mucin-1 in the mechanism of liver ischemia and reperfusion injury in the mouse.

Uchida Y, Ke B, Freitas MC, Ji H, Zhao D, Benjamin ER, Najafian N, Yagita H, Akiba H, Busuttil RW, Kupiec-Weglinski JW.

Hepatology. 2010 Apr;51(4):1363-72. doi: 10.1002/hep.23442.

16.
17.

Tim-3 exacerbates kidney ischaemia/reperfusion injury through the TLR-4/NF-κB signalling pathway and an NLR-C4 inflammasome activation.

Guo Y, Zhang J, Lai X, Chen M, Guo Y.

Clin Exp Immunol. 2018 Jul;193(1):113-129. doi: 10.1111/cei.13126. Epub 2018 May 7.

18.

IL-17A blockade or deficiency does not affect progressive renal fibrosis following renal ischaemia reperfusion injury in mice.

Thorenz A, Völker N, Bräsen JH, Chen R, Jang MS, Rong S, Haller H, Kirsch T, Vieten G, Klemann C, Gueler F.

J Pharm Pharmacol. 2017 Sep;69(9):1125-1135. doi: 10.1111/jphp.12747. Epub 2017 Jun 2.

PMID:
28573734
19.

Superagonistic CD28 Protects against Renal Ischemic Injury by Expansion of Regulatory T-Cell.

Liang Y, Li Y, Kuang Q, Ding X, Wei Z, Fang Y.

Am J Nephrol. 2017;45(5):389-399. doi: 10.1159/000470918. Epub 2017 Mar 29.

PMID:
28355607
20.

Arginase-2 mediates renal ischemia-reperfusion injury.

Raup-Konsavage WM, Gao T, Cooper TK, Morris SM Jr, Reeves WB, Awad AS.

Am J Physiol Renal Physiol. 2017 Aug 1;313(2):F522-F534. doi: 10.1152/ajprenal.00620.2016. Epub 2017 May 17. Retraction in: Am J Physiol Renal Physiol. 2017 Oct 1;313(4):F1060.

Supplemental Content

Support Center